Literature DB >> 2008942

A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block.

R Hickey1, J Hoffman, S Ramamurthy.   

Abstract

This study compared the effectiveness of 0.5% ropivacaine and 0.5% bupivacaine for brachial plexus block. Forty-eight patients received a subclavian perivascular brachial plexus block for upper-extremity surgery. One group (n = 24) received ropivacaine 0.5% (175 mg) and a second group (n = 24) received bupivacaine 0.5% (175 mg), both without epinephrine. Onset times for analgesia and anesthesia in each of the C5 through T1 brachial plexus dermatomes did not differ significantly between groups. Duration of analgesia and anesthesia was long (mean duration of analgesia, 13-14 h; mean duration of anesthesia, 9-11 h) and also did not differ significantly between groups. Motor block was profound, with shoulder paralysis as well as hand paresis developing in all of the patients in both groups. Two patients in each group required supplemental blocks before surgery. Ropivacaine 0.5% and bupivacaine 0.5% appeared equally effective in providing brachial plexus anesthesia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008942     DOI: 10.1097/00000542-199104000-00002

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

1.  Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS.

Authors:  J D Harkins; W Karpiesiuk; T Tobin; L Dirikolu; A F Lehner
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

Review 2.  Long-acting local anesthetics in dentistry.

Authors:  A L Sisk
Journal:  Anesth Prog       Date:  1992

Review 3.  Adverse effects and drug interactions associated with local and regional anaesthesia.

Authors:  M Naguib; M M Magboul; A H Samarkandi; M Attia
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

Review 4.  Complications of regional anaesthesia Incidence and prevention.

Authors:  K A Faccenda; B T Finucane
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Pharmacokinetics and efficacy of 40 ml ropivacaine 7.5 mg/ml (300 mg), for axillary brachial plexus block--an open pilot study.

Authors:  W Wank; J Büttner; K Rissler Maier; B M Emanuelson; D Selander
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

Review 6.  Ropivacaine: an update of its use in regional anaesthesia.

Authors:  K J McClellan; D Faulds
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

7.  Perineural dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat.

Authors:  Chad M Brummett; Amrita K Padda; Francesco S Amodeo; Kathleen B Welch; Ralph Lydic
Journal:  Anesthesiology       Date:  2009-11       Impact factor: 7.892

8.  No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.

Authors:  John W Barrington; Roger H Emerson; Scott T Lovald; Adolph V Lombardi; Keith R Berend
Journal:  Clin Orthop Relat Res       Date:  2017-01       Impact factor: 4.176

9.  Efficacy and safety of 1% ropivacaine for postoperative analgesia after lower third molar surgery: a prospective, randomized, double-blinded clinical study.

Authors:  Božidar Brković; Miroslav Andrić; Dejan Ćalasan; Marija Milić; Jelena Stepić; Milan Vučetić; Denis Brajković; Ljubomir Todorović
Journal:  Clin Oral Investig       Date:  2016-04-25       Impact factor: 3.573

10.  Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.

Authors:  Chad M Brummett; Mary A Norat; John M Palmisano; Ralph Lydic
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.